Resultats de la cerca - Ellison Themeles
- Mostrar 1 - 10 resultats de 10
-
1
Causes of Death and Influencing Factors in Patients With Atrial Fibrillation per Éloi Marijon, Jean‐Yves Le Heuzey, Stuart J. Connolly, Sean Yang, Janice Pogue, Martina Brueckmann, John W. Eikelboom, Ellison Themeles, Michael D. Ezekowitz, Lars Wallentin, Salim Yusuf
Publicat 2013Artigo -
2
Response to Letters Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Ter... per Jeff S. Healey, John W. Eikelboom, Sean Yang, Ellison Themeles, Stuart J. Connolly, Salim Yusuf, James D. Douketis, Lars Wallentin, Jonas Oldgren, Hein Heidbüchel, Álvaro Avezum, Paul Reilly, Michael D. Ezekowitz
Publicat 2013Carta -
3
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin per Jeff S. Healey, John W. Eikelboom, James D. Douketis, Lars Wallentin, Jonas Oldgren, Sean Yang, Ellison Themeles, Hein Heidbüchel, Álvaro Avezum, Paul Reilly, Stuart J. Connolly, Salim Yusuf, Michael D. Ezekowitz
Publicat 2012Artigo -
4
Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis per Jonathan D. Adachi, W. Bensen, Mary Bell, F Bianchi, Alfred Cividino, Gary L. Craig, W. C. Sturtridge, R. J. Sebaldt, Marjorie Steele, Matthew J. Gordon, Ellison Themeles, Peter Tugwell, Robin Roberts, M.J. van Gent
Publicat 1997Artigo -
5
Subclinical Atrial Fibrillation and the Risk of Stroke per Jeff S. Healey, Stuart J. Connolly, Michael R. Gold, Carsten W. Israel, Isabelle C. Van Gelder, Alessandro Capucci, C.P. Lau, Eric Fain, Sean Yang, Christophe Bailleul, Carlos A. Morillo, Mark D. Carlson, Ellison Themeles, Elizabeth S. Kaufman, Stefan H. Hohnloser
Publicat 2012Artigo -
6
Dabigatran versus Warfarin in Patients with Atrial Fibrillation per Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John W. Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Díaz, Basil S. Lewis, Harald Darius, Hans‐Christoph Diener, Campbell Joyner, Lars Wallentin
Publicat 2009Artigo -
7
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial per Robert G. Hart, Mukul Sharma, Hardi Mundl, Ashkan Shoamanesh, Scott E. Kasner, Scott D. Berkowitz, Guillaume Paré, Bodo Kirsch, Janice Pogue, C. Pater, Gary Peters, Antoni Dávalos, Wilfried Lang, Yongjun Wang, Yilong Wang, Luís Cunha, Jens Eckstein, Turgut Tatlisumak, N. А. Shamalov, Robert Mikulík, Pablo M. Lavados, Graeme J. Hankey, Anna Członkowska, Danilo Toni, Sebastián F. Ameriso, Rubens José Gagliardi, Pierre Amarenco, Dániel Bereczki, Shinichiro Uchiyama, Arne Lindgren, Matthias Endres, Raf Brouns, Byung‐Woo Yoon, George Ntaios, Roland Veltkamp, Keith W. Muir, Şerefnur Öztürk, Antonio Araúz, Natan M. Bornstein, Alan Bryer, Martin O’Donnell, Jeffrey I. Weitz, Frank Peacock, Ellison Themeles, Stuart J. Connolly
Publicat 2016Artigo -
8
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial per Scott E. Kasner, Pablo M. Lavados, Mukul Sharma, Yongjun Wang, Yilong Wang, Antoni Dávalos, N. А. Shamalov, Luís Cunha, Cecilia M. Lindgren, Robert Mikulík, Antonio Araúz, Wilfried Lang, Anna Członkowska, Jens Eckstein, Rubens José Gagliardi, Pierre Amarenco, Sebastián F. Ameriso, Turgut Tatlisumak, Roland Veltkamp, Graeme J. Hankey, Danilo Toni, Dániel Bereczki, Shinichiro Uchiyama, George Ntaios, Byung‐Woo Yoon, Raf Brouns, M.M. DeVries Basson, Matthias Endres, Keith W. Muir, Natan M. Bornstein, Şerefnur Öztürk, Martin O’Donnell, Hardi Mundl, C. Pater, Jeffrey I. Weitz, W. Frank Peacock, Balakumar Swaminathan, Bodo Kirsch, Scott D. Berkowitz, Gary Peters, Guillaume Paré, Ellison Themeles, Ashkan Shoamanesh, Stuart J. Connolly, Robert G. Hart
Publicat 2018Artigo -
9
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source per Robert G. Hart, Mukul Sharma, Hardi Mundl, Scott E. Kasner, Shrikant I. Bangdiwala, Scott D. Berkowitz, Balakumar Swaminathan, Pablo M. Lavados, Yongjun Wang, Yilong Wang, Antonio Dávalos, N. А. Shamalov, Robert Mikulík, Luís Cunha, Arne Lindgren, Antonio Araúz, Wilfried Lang, Anna Członkowska, Jens Eckstein, Rubens José Gagliardi, Pierre Amarenco, Sebastián F. Ameriso, Turgut Tatlisumak, Roland Veltkamp, Graeme J. Hankey, Danilo Toni, Dániel Bereczki, Shinichiro Uchiyama, George Ntaios, Byung‐Woo Yoon, Raf Brouns, Matthias Endres, Keith W. Muir, Natan M. Bornstein, Şerefnur Öztürk, Martin O’Donnell, Matthys M. De Vries Basson, Guillaume Paré, Calin Pater, Bodo Kirsch, Patrick Sheridan, Gary Peters, Jeffrey I. Weitz, W. Frank Peacock, Ashkan Shoamanesh, Oscar Benavente, Campbell Joyner, Ellison Themeles, Stuart J. Connolly
Publicat 2018Carta -
10
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study per Stuart J. Connolly, Lars Wallentin, Michael D. Ezekowitz, John W. Eikelboom, Jonas Oldgren, Paul Reilly, Martina Brueckmann, Janice Pogue, Marco Alings, John Amerena, Álvaro Avezum, Iris Baumgärtner, Andrzej Budaj, Jyh-Hong Chen, Antonio L. Dans, Harald Darius, Giuseppe Di Pasquale, Jorge Ferreira, Greg C. Flaker, Marcus Flather, Maria Grazia Franzosi, Golitsyn Sp, David A. Halon, Hein Heidbüchel, Stefan H. Hohnloser, Kurt Huber, Petr Janský, Gabriel Kamenský, Matyàs Keltai, Sung Soon Kim, Chu‐Pak Lau, Jean-Yves Le Heuzey, Basil S. Lewis, Lisheng Liu, John N. Nanas, Razali Omar, Prem Pais, Knud Erik Pedersen, Leopoldo Soares Piegas, Dimitar Raev, Pål J. Smith, Mario Talajic, Ru San Tan, Supachai Tanomsup, Lauri Toivonen, Dragoş Vinereanu, Denis Xavier, Jun Zhu, Susan Q. Wang, Christine Duffy, Ellison Themeles, Salim Yusuf
Publicat 2013Artigo
Eines de cerca:
Matèries relacionades
Internal medicine
Medicine
Atrial fibrillation
Warfarin
Engineering
Mechanical engineering
Stroke (engine)
Cardiology
Dabigatran
Randomized controlled trial
Rivaroxaban
Anesthesia
Confidence interval
Aspirin
Embolism
Environmental health
Hazard ratio
Intensive care medicine
Myocardial infarction
Population
Surgery
Alternative medicine
Apixaban
Bone density
Bone mineral
Calcitonin
Cohort
Corticosteroid
Direct thrombin inhibitor
Embolic stroke